Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 26 2021 - 12:57PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2021
Commission File Number: 001-40360
MIND MEDICINE (MINDMED) INC.
(Name of registrant)
One World Trade Center
Suite 8500
New York, New York 10007
(Address of principal
executive office)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
¨ Form
20-F x Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
MIND MEDICINE (MINDMED) INC.
|
|
|
(Registrant)
|
|
|
|
|
|
Date: May 26, 2021
|
By:
|
/s/ Collin Gage
|
|
|
|
Name: Collin Gage
|
|
|
|
Title: Vice President of Corporate Development
|
|
|
|
|
Form 6-K Exhibit Index
Mind Medicine MindMed (NASDAQ:MNMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Mind Medicine MindMed (NASDAQ:MNMD)
Historical Stock Chart
From Sep 2023 to Sep 2024